Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Corporate Governance
2026.03.31
三里枫香：独立董事2025年度述职报告（吕川）
2026.03.31
三里枫香：独立董事2025年度述职报告（黄鹏）
2026.03.31
三里枫香：董事会审计委员会对会计师事务所2025年度履职情况评估及履行监督职责情况的报告
2026.03.31
三里枫香：董事会关于2025年度独立董事独立性评估的专项意见
2025.12.17
三里枫香：公司章程
2025.12.17
三里枫香：股东会议事规则
2025.12.17
三里枫香：董事会议事规则
2025.12.17
三里枫香：内部审计管理制度
2025.12.17
三里枫香：投资者关系管理制度
2025.12.17
三里枫香：信息披露事务管理制度
第一页
上一页
1
2
3
4
5
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
